Paul R. Edick, See Remarks at XERIS PHARMACEUTICALS INC (XERS), bought 10,000 shares at $4.06 ($41K) on 2020-12-09, disclosed to the SEC on 2020-12-10.
Open-market purchase of $41k XERS by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2022-05-13 | $140K | — | Filing → |
| XERS | BUY | 2021-11-16 | $46K | — | Filing → |
| XERS | BUY | 2021-11-12 | $416K | — | Filing → |